Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

3.00
Delayed Data
As of Jun 23
 +0.15 / +5.26%
Today’s Change
1.96
Today|||52-Week Range
4.55
0.00%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close2.85
Today’s open2.85
Day’s range2.85 - 3.00
Volume403,465
Average volume (3 months)303,101
Market cap$98.3M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+32.42%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.10-1.80%
ACRXAcelRx Pharmaceutica...-0.25-10.42%
ORMPOramed Pharmaceutica...+0.10+1.36%
ZFGNZafgen Inc-0.09-2.37%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts